Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5

(2015) John B. Buse et al.   DIABETES CARE

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids

(2015) Daniel F. Vatner et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

(2014) Philip Home et al.   DIABETES CARE

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2014) Silvio E. Inzucchi et al.   DIABETES CARE

Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

(2014) Robert R. Henry et al.   DIABETES CARE

Insulin Analogs—Is There a Compelling Case to Use Them? No!: Table 1

(2014) Mayer B. Davidson   DIABETES CARE

Estimation of group means when adjusting for covariates in generalized linear models

(2014) Yongming Qu et al.   PHARMACEUTICAL STATISTICS

Tonic regulation of vascular permeability

(2013) F.-R. E. Curry et al.   Acta Physiologica

Management of type 2 diabetes: NICE guidelines

(2013) L. Sibal et al.   CLINICAL MEDICINE

Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism

(2013) M. C. Moore et al.   DIABETES

Steady-state pharmacokinetics and glucodynamics of the novel, long-acting basal insulin LY2605541 dosed once-daily in patients with type 2 diabetes mellitus

(2013) V. P. Sinha et al.   DIABETES OBESITY & METABOLISM

Hepatoselectivity and the evolution of insulin

(2013) R. Herring et al.   DIABETES OBESITY & METABOLISM

The Effect of Adjusting for Baseline Hypoglycemia when Analyzing Hypoglycemia Data: A Systematic Analysis of 15 Diabetes Clinical Trials

(2013) Junxiang Luo et al.   Diabetes Technology & Therapeutics

Basal insulin analogues in the management of diabetes mellitus: what progress have we made?

(2013) David R. Owens et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Analysis of hypoglycemic events using negative binomial models

(2013) Junxiang Luo et al.   PHARMACEUTICAL STATISTICS

Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes

(2009) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

(2008) Martin Adiels et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials

(2008) L. A. Bazzano et al.   DIABETIC MEDICINE

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

(2008) J. Rosenstock et al.   DIABETOLOGIA

A note on tree gatekeeping procedures in clinical trials

(2008) Alex Dmitrienko et al.   STATISTICS IN MEDICINE